Key facts
- May Health’s last known valuation is $54.2M.
- It has raised $37.1M; the latest was Later Stage VC ($24.9M) in May 2024.
- Notable investors include US National Science Foundation, Bpifrance, MedTech Innovator, StartX (US), Sofinnova Partners — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for May Health
- ·The full record, as it builds
Funding rounds
No funding rounds for May Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About May Health
Developer of investigative ablation technology designed to restore ovulation in women with PCOS-related infertility. The company's technology offers a procedure that is designed to assist the body to ovulate as it naturally would through a one-time intervention performed in the medical clinic, enabling patients to be treated for polycystic ovary syndrome through a simple, one-time, durable and minimally invasive treatment.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2014
- Employees
- 18
- Website
- mayhealth.com/
- Ownership
- Privately Held (backing)
May Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in May Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on May Health in its N-PORT filings yet. We sweep new filings monthly.